article thumbnail

EU gives narrower label to Apellis, Sobi’s PNH drug

pharmaphorum

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The post EU gives narrower label to Apellis, Sobi’s PNH drug appeared first on.

article thumbnail

Can you drink coffee while taking prednisone?

The Checkup by Singlecare

It is used to control inflammation by suppressing the immune system,” says Jelena Radan, Pharm.D. According to a 2017 study , the beverage acts in an anti-inflammatory manner on different components of the immune system, such as natural killer (NK) cells, monocytes, and neutrophils. ” These may be taken without food.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can you drink on Mucinex?

The Checkup by Singlecare

In addition, the FDA label for the nighttime forms of Mucinex containing acetaminophen recommends avoiding three or more drinks per day. Effects on the immune system Alcohol may negatively affect your immune system’s ability to fight off infections, especially in people who drink large amounts over time.

article thumbnail

Current and future players in the lupus market

Pharmaceutical Technology

The management of SLE and LN consists largely of treatment options that are based on highly efficacious steroids or immune-suppressive therapy with an undesirable safety profile, which includes accrued organ damage, infections and cancer. in 2018 across the 7MM despite being an off-label therapy for lupus.

Labelling 111
article thumbnail

Phase III trial shows tislelizumab improves outcomes for liver cancer patients

European Pharmaceutical Review

HCC accounted for more approximately 85 percent of the 900,000 new liver cancer cases in 2020, according to the Globocan 2020 database. . The RATIONALE 301 Phase III randomised, open-label study included more than 600 patients in the US, Europe and Asia. About tislelizumab.

article thumbnail

US FDA accepts Regeneron’s pozelimab BLA for priority review

Pharmaceutical Technology

Currently, there are no approved treatments for CHAPLE, a life-threatening hereditary immune disease caused by an overactivation of the complement system. The investigational, fully human monoclonal antibody, Pozelimab has been designed to block the complement factor C5 activity. The regulatory body is expected to decide on 20 August.

FDA 52
article thumbnail

What is the best probiotic for vaginal health?

The Checkup by Singlecare

Probiotics and vaginal health | Types of probiotics | Choosing a probiotic | Optimizing vaginal health | FAQs | The bottom line | Sources Probiotics for gut health and improved host immunity recently became a trending health topic. Overall, immune system modulation has many health benefits.